Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients

May Abd Al Samid, Belal Chaudhary, Yazan S. Khaled, Basil J. Ammori, Eyad Elkord

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)


Regulatory T cells (Tregs) comprise numerous heterogeneous subsets with distinct phenotypic and functional features. Identifying Treg markers is critical to investigate the role and clinical impact of various Treg subsets in pathological settings, and also for developing more effective immunotherapies. We have recently shown that non-activated FoxP3-Helios+ and activated FoxP3+/-Helios+ CD4+ T cells express GARP/LAP immunosuppressive markers in healthy donors. In this study we report similar observations in the peripheral blood of patients with pancreatic cancer (PC) and liver metastases from colorectal cancer (LICRC). Comparing levels of different Treg subpopulations in cancer patients and controls, we report that in PC patients, and unlike LICRC patients, there was no increase in Treg levels as defined by FoxP3 and Helios. However, defining Tregs based on GARP/LAP expression showed that FoxP3-LAP+ Tregs in non-activated and activated settings, and FoxP3+Helios+GARP+LAP+ activated Tregs were significantly increased in both groups of patients, compared with controls. This work implies that a combination of Treg-specific markers could be used to more accurately determine expanded Treg subsets and to understand their contribution in cancer settings. Additionally, GARP-/+LAP+ CD4+ T cells made IL-10, and not IFN-γ, and levels of IL-10-secreting CD4+ T cells were elevated in LICRC patients, especially with higher tumor staging. Taken together, our results indicate that investigations of Treg levels in different cancers should consider diverse Treg-related markers such as GARP, LAP, Helios, and others and not only FoxP3 as a sole Treg-specific marker.

Original languageEnglish
Pages (from-to)14083-14094
Number of pages12
Issue number12
Publication statusPublished - Mar 22 2016


  • FoxP3
  • Helios
  • Markers
  • Regulatory T cells

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients'. Together they form a unique fingerprint.

Cite this